Lymphedema is a common complication of axillary dissection and thus emphasis should be placed on prevention. Fifty-five women who had breast-conserving surgery or modified radical mastectomy for breast cancer with axillary dissection were randomly assigned to either the preventive protocol (PG) or control group (CG) and assessments were made preoperatively and at 1,3,6,12 and 24 months postoperatively. Arm volume (VOL) was used as measurement of arm lymphedema. Clinically significant lymphedema was confirmed by an increase of at least 200 ml from the preoperative difference between the two arms. The preventive protocol for the PG women included preoperative upper limb lymphscintigraphy (LS), principles for lymphedema risk minimization, and ...
We performed a prospective randomized study upon 50 patients who had undergone a breast cancer treat...
A prospective study was conducted to identify women at increased risk for lymphoedema (LE) based on ...
Background: Breast cancer- related lymphedema (BCRL) affects about 3 to 5 million patients ...
Lymphedema is a common complication of axillary dissection and thus emphasis should be placed on pre...
PURPOSE: To prospectively assess the efficacy of the lymphatic microsurgical preventive healing appr...
The development of secondary arm lymphoedema after the removal of axillary lymph nodes remains a pot...
Secondary lymphoedema of the upper limbs is a fairly frequent complication of breast cancer treatmen...
Breast cancer-related lymphedema (LE) represents an important morbidity that jeopardizes breast canc...
The secondary lymphedema of the upper limb (post-mastectomy lymphedema) has an incidence, in patient...
BACKGROUND: Early detection and multimodality therapy has resulted in an overall improvement of surv...
Authors report anatomical and pathophysiologic aspects concerning lymphedema following breast cancer...
BACKGROUND: Early detection and multimodality therapy has resulted in an overall improvement of surv...
BACKGROUND: The purpose of this manuscript is to assess the efficacy of direct lymphatic venous micr...
Background: Lymphedema is one of the major long-term complications of axillary dissection. This stud...
BACKGROUND: Early detection and multimodality therapy has resulted in an overall improvement of sur...
We performed a prospective randomized study upon 50 patients who had undergone a breast cancer treat...
A prospective study was conducted to identify women at increased risk for lymphoedema (LE) based on ...
Background: Breast cancer- related lymphedema (BCRL) affects about 3 to 5 million patients ...
Lymphedema is a common complication of axillary dissection and thus emphasis should be placed on pre...
PURPOSE: To prospectively assess the efficacy of the lymphatic microsurgical preventive healing appr...
The development of secondary arm lymphoedema after the removal of axillary lymph nodes remains a pot...
Secondary lymphoedema of the upper limbs is a fairly frequent complication of breast cancer treatmen...
Breast cancer-related lymphedema (LE) represents an important morbidity that jeopardizes breast canc...
The secondary lymphedema of the upper limb (post-mastectomy lymphedema) has an incidence, in patient...
BACKGROUND: Early detection and multimodality therapy has resulted in an overall improvement of surv...
Authors report anatomical and pathophysiologic aspects concerning lymphedema following breast cancer...
BACKGROUND: Early detection and multimodality therapy has resulted in an overall improvement of surv...
BACKGROUND: The purpose of this manuscript is to assess the efficacy of direct lymphatic venous micr...
Background: Lymphedema is one of the major long-term complications of axillary dissection. This stud...
BACKGROUND: Early detection and multimodality therapy has resulted in an overall improvement of sur...
We performed a prospective randomized study upon 50 patients who had undergone a breast cancer treat...
A prospective study was conducted to identify women at increased risk for lymphoedema (LE) based on ...
Background: Breast cancer- related lymphedema (BCRL) affects about 3 to 5 million patients ...